![CH-2024_S2_podcast_Share-image_1400x800-3](https://collectivehealth.com/wp-content/uploads/2024/07/CH-2024_S2_podcast_Share-image_1400x800-3-1524x871.jpg 1524w, https://collectivehealth.com/wp-content/uploads/2024/07/CH-2024_S2_podcast_Share-image_1400x800-3-300x171.jpg 300w, https://collectivehealth.com/wp-content/uploads/2024/07/CH-2024_S2_podcast_Share-image_1400x800-3-768x439.jpg 768w, https://collectivehealth.com/wp-content/uploads/2024/07/CH-2024_S2_podcast_Share-image_1400x800-3-1536x878.jpg 1536w, https://collectivehealth.com/wp-content/uploads/2024/07/CH-2024_S2_podcast_Share-image_1400x800-3-2048x1170.jpg 2048w, https://collectivehealth.com/wp-content/uploads/2024/07/CH-2024_S2_podcast_Share-image_1400x800-3-16x9.jpg 16w, https://collectivehealth.com/wp-content/uploads/2024/07/CH-2024_S2_podcast_Share-image_1400x800-3-1200x686.jpg 1200w, https://collectivehealth.com/wp-content/uploads/2024/07/CH-2024_S2_podcast_Share-image_1400x800-3-1980x1131.jpg 1980w)
Strategies for managing pharmacy, gene therapy, and GLP-1s with Doug Ramsthel and Jaclyn Rielly
In this episode of The Benefits Playbook, guests Doug Ramsthel and Jaclyn Rielly of Burnham Benefits discuss how the shift in pharmacy is affecting employers and members.